(Q39016327)

English

Berbamine enhances the antineoplastic activity of gemcitabine in pancreatic cancer cells by activating transforming growth factor-β/Smad signaling

scientific article published on 12 March 2014

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Berbamine enhances the antineoplastic activity of gemcitabine in pancreatic cancer cells by activating transforming growth factor-β/Smad signaling (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

pancreatic cancer

1 reference

based on heuristic

inferred from title

author name string

Xiaoli Jin

1

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Yulian Wu

2

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

publication date

12 March 2014

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

The Anatomical Record

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

297

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

802-809

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death

1 reference

https://api.crossref.org/works/10.1002%2FAR.22897

21 January 2018

Molecular events associated with reactive oxygen species and cell cycle progression in mammalian cells

1 reference

https://api.crossref.org/works/10.1002%2FAR.22897

21 January 2018

Adenosquamous carcinoma of the pancreas harbors KRAS2, DPC4 and TP53 molecular alterations similar to pancreatic ductal adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FAR.22897

21 January 2018

A role for transcriptional repression of p21CIP1 by c-Myc in overcoming transforming growth factor beta -induced cell-cycle arrest

1 reference

https://api.crossref.org/works/10.1002%2FAR.22897

21 January 2018

Cell death: critical control points

1 reference

https://api.crossref.org/works/10.1002%2FAR.22897

21 January 2018

Role of transforming growth factor-beta signaling in cancer

1 reference

https://api.crossref.org/works/10.1002%2FAR.22897

21 January 2018

Suppression of human lung cancer cell growth and migration by berbamine

1 reference

https://api.crossref.org/works/10.1002%2FAR.22897

21 January 2018

Alterations of cell signaling pathways in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FAR.22897

21 January 2018

Potentiation of the effect of gemcitabine by emodin in pancreatic cancer is associated with survivin inhibition

1 reference

https://api.crossref.org/works/10.1002%2FAR.22897

21 January 2018

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1002%2FAR.22897

21 January 2018

Cell-cycle checkpoints and cancer

1 reference

https://api.crossref.org/works/10.1002%2FAR.22897

21 January 2018

In vivo disruption of TGF-beta signaling by Smad7 leads to premalignant ductal lesions in the pancreas

1 reference

https://api.crossref.org/works/10.1002%2FAR.22897

21 January 2018

TGF-beta signaling and the fibrotic response

1 reference

https://api.crossref.org/works/10.1002%2FAR.22897

21 January 2018

Smad4 dependency defines two classes of transforming growth factor {beta} (TGF-{beta}) target genes and distinguishes TGF-{beta}-induced epithelial-mesenchymal transition from its antiproliferative and migratory responses

1 reference

https://api.crossref.org/works/10.1002%2FAR.22897

21 January 2018

Ubiquitination and proteolysis of cancer-derived Smad4 mutants by SCFSkp2

1 reference

https://api.crossref.org/works/10.1002%2FAR.22897

21 January 2018

Berbamine inhibits proliferation and induces apoptosis of KU812 cells by increasing Smad3 activity

1 reference

https://api.crossref.org/works/10.1002%2FAR.22897

21 January 2018

A novel calmodulin antagonist O-(4-ethoxyl-butyl)-berbamine overcomes multidrug resistance in drug-resistant MCF-7/ADR breast carcinoma cells

1 reference

https://api.crossref.org/works/10.1002%2FAR.22897

21 January 2018

Mammalian cell cycle checkpoints: signalling pathways and their organization in space and time

1 reference

https://api.crossref.org/works/10.1002%2FAR.22897

21 January 2018

TGF-beta signal transduction

1 reference

https://api.crossref.org/works/10.1002%2FAR.22897

21 January 2018

Recent advances on the molecular mechanisms involved in the drug resistance of cancer cells and novel targeting therapies

1 reference

https://api.crossref.org/works/10.1002%2FAR.22897

21 January 2018

Differential ubiquitination defines the functional status of the tumor suppressor Smad4.

1 reference

https://api.crossref.org/works/10.1002%2FAR.22897

21 January 2018

bcl-2-specific siRNAs restore gemcitabine sensitivity in human pancreatic cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FAR.22897

21 January 2018

Smad pathway-specific transcriptional regulation of the cell cycle inhibitor p21(WAF1/Cip1).

1 reference

https://api.crossref.org/works/10.1002%2FAR.22897

21 January 2018

Phase II study of gemcitabine and cisplatin in the treatment of patients with advanced pancreatic carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FAR.22897

21 January 2018

Pancreatic cancer in the general population: Improvements in survival over the last decade.

1 reference

https://api.crossref.org/works/10.1002%2FAR.22897

21 January 2018

FTY720, a synthetic compound from Isaria sinclairii, inhibits proliferation and induces apoptosis in pancreatic cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FAR.22897

21 January 2018

Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer

1 reference

https://api.crossref.org/works/10.1002%2FAR.22897

21 January 2018

Cancer statistics, 2012

1 reference

https://api.crossref.org/works/10.1002%2FAR.22897

21 January 2018

Transforming growth factor-beta suppressed Id-1 Expression in a smad3-dependent manner in LoVo cells.

1 reference

https://api.crossref.org/works/10.1002%2FAR.22897

21 January 2018

Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.

1 reference

https://api.crossref.org/works/10.1002%2FAR.22897

21 January 2018

The antiproliferation effect of berbamine on k562 resistant cells by inhibiting NF-kappaB pathway

1 reference

https://api.crossref.org/works/10.1002%2FAR.22897

21 January 2018

Mechanism of activation of the TGF-beta receptor

1 reference

https://api.crossref.org/works/10.1002%2FAR.22897

21 January 2018

TGF-beta signaling alterations and susceptibility to colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FAR.22897

21 January 2018

Gefitinib inhibits the proliferation of pancreatic cancer cells via cell cycle arrest

1 reference

https://api.crossref.org/works/10.1002%2FAR.22897

21 January 2018

Identifiers

10.1002/AR.22897

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39016327&oldid=1802461403"